YUBO INTERNATIONAL BIOTECH LIMITED
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Mar 2026 | Nov 2025 | Sep 2025 | Aug 2025 | Jun 2025 | May 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | $0 | — | $0 | — |
| Cost of Revenue | $0 | $0 | — | — | $0 | — | $0 | — |
| Gross Profit | $0 | $0 | — | — | $0 | — | $0 | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-238.9K | $-289.3K | — | — | $-310.1K | — | $-249.7K | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | $18 | — | $23 | — |
| Pretax Income | $-268.7K | $-295.0K | — | — | $-310.2K | — | $-249.7K | — |
| Income Tax Expense | $0 | $0 | — | — | $0 | — | $0 | — |
| Net Income | $-247.9K | $-272.6K | — | — | $-310.2K | — | $-230.3K | — |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | $0.00 | $0.00 | — | — | $0.00 | — | $0.00 | — |
| Shares Outstanding (Basic) | — | — | 170.4M | 170.4M | — | 170.4M | — | 119.8M |
| Shares Outstanding (Diluted) | 170.4M | 170.4M | 170.4M | 170.4M | 147.9M | 170.4M | 119.8M | 119.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |